MSCI announces November index changes, adds Moderna to World Index

What happened

MSCI announced its November 2026 Equity Index Review. Moderna will join the MSCI World Index as the U.S. addition, alongside Canada's Aritzia. The MSCI U.S. Prime Market 750 Index will add 10 securities and remove eight, with all listed changes taking effect after trading closes on November 30, 2026.

Confirmed

Global impact / market context

Index membership can influence which shares funds that track or compare themselves with an index buy or sell. As a result, Moderna and the other additions could see demand from index-linked portfolios, while removed securities could face selling; the article gives no estimates of those flows.

Analyst inference

The review spans large, small, and micro-cap U.S. indexes as well as the global MSCI World Index. These scheduled changes alter index composition, but the article provides no details on expected trading volumes, price effects, or how much money tracks the indexes.

Analyst inference

What to watch

1. Check whether MSCI confirms any further review details before the changes take effect after the close of trading on November 30, 2026. Analyst inference
2. Watch for reports of buying or selling by funds that track the affected indexes, since index changes may require them to adjust holdings. Analyst inference
3. Compare trading in the newly added and removed securities around the effective date; the article does not state expected flows or price impacts. Analyst inference

Evidence

• seekingalpha.com